Recruiting

Cryotherapy

Sponsor:

NYU Langone Health

Code:

NCT07184957

Conditions

Prostate Cancer

Eligibility Criteria

Sex: Male

Age: 40 - 70+

Healthy Volunteers: Not accepted

Study Details

Brief summary:

This will be a prospectively maintained research database. The purpose is to record baseline parameters and treatment outcomes following of Cryotherapy for ablation of clinically localized prostate cancer.

Conditions

Prostate Cancer

Study ID

NCT07184957

Start date

May 1, 2017

Status verified date

Aug, 2026

Completion date

Dec 31, 2040

Anticipated

Primary completion date

Dec 31, 2030

Anticipated

Eligibility Criteria

Eligibility Criteria

Sex: Male

Age: 40 - 70+

Healthy Volunteers: Not accepted

Inclusion Criteria:

  • Evidence of focal prostate cancer confined to the prostate based on MRI imaging and prostate biopsy
  • Patients with clinically localized prostate cancer (no evidence for or concern for metastatic spread of cancer outside of the prostate) will be counseled regarding treatment options. Those selecting focal Cryo prostate ablation will then be offered inclusion into this data collection.

Exclusion Criteria:

  • Men that are not diagnosed with prostate cancer.
  • Men that are diagnosed with clinically localized prostate cancer, but select other treatment options as their desired treatment.

Study Design

Enrollment

1000 participants

Anticipated

Interventions and Outcome Measures

Arms

Men with Prostate Cancer

Men who receive cryotherapy for ablation of clinically localized prostate cancer.

Primary outcome measure

  • Treatment Complications [ Time Frame: Up to Year 15 ]
  • PSA-Progression Free Survival [ Time Frame: Up to Year 15 ]

Central Contacts and Locations

Central contacts

Majlinda Tafa

(646) 825-6338Majlinda.Tafa@nyulangone.org

James Wysock, MD

(646) 825-6366James.Wysock@nyulangone.org

Locations

NYU Langone Health

Recruiting

New York, New York, United States, 10016

More Information

Sponsor

NYU Langone Health

Last update posted

Aug 7, 2026

Last verified

Aug, 2026

Trial information was received from ClinicalTrials.gov and was last updated on 2026-09-10. This information was provided to ClinicalTrials.gov by NYU Langone Health on 2026-08-07.